BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 21362031)

  • 21. Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience.
    Park YW; Yeom KB; Choi JW; Kim DY; Shin H; Kim KH
    J Dermatolog Treat; 2014 Oct; 25(5):391-5. PubMed ID: 23273264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Propanolol used in treatment of infantile hemangioma].
    Guldbakke KK; Rørdam OM; Huldt-Nystrøm T; Hanssen HK; Høivik F
    Tidsskr Nor Laegeforen; 2010 Sep; 130(18):1822-4. PubMed ID: 20882080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas.
    Maturo S; Hartnick C
    Int J Pediatr Otorhinolaryngol; 2010 Mar; 74(3):323-5. PubMed ID: 20071038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of propranolol for infantile hemangiomas.
    Küpeli S
    Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of propranolol for treatment of hemangiomas in PHACE syndrome.
    Solomon T; Ninnis J; Deming D; Merritt TA; Hopper A
    J Perinatol; 2011 Nov; 31(11):739-41. PubMed ID: 22037156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
    Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth characteristics of infantile hemangiomas: implications for management.
    Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
    Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
    Phillips RJ; Penington AJ; Bekhor PS; Crock CM
    J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study.
    Malik MA; Menon P; Rao KL; Samujh R
    J Pediatr Surg; 2013 Dec; 48(12):2453-9. PubMed ID: 24314186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma].
    Zhao ZF; Lü RR; Zhang J; Huo R; Xu GQ; Fu HB; Guo X; Wui JC; Lin LL
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):174-7. PubMed ID: 21837994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol for the treatment of subglottic hemangiomas.
    Raol N; Metry D; Edmonds J; Chandy B; Sulek M; Larrier D
    Int J Pediatr Otorhinolaryngol; 2011 Dec; 75(12):1510-4. PubMed ID: 21944056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.